FDASRA Act of 2022
Summary
Food and Drug Administration Simple Reauthorization Act of 2022 or the FDASRA Act of 2022 This bill reauthorizes the authority of the Food and Drug Administration to collect certain fees related to drugs, medical devices, and biosimilar biological products and modifies such fees, including the base fee amounts.
Bill status
in committee
1 of 4 stages cleared
Introduction
Jul 2022
Committee Review
Floor Vote
President
Introduced Jul 14, 2022
Last action Jul 14, 2022
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
2
Key actions
0
Committee
1
Jul 14, 2022
Committee
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
upper
Jul 14, 2022
Introduced
Introduced in Senate
upper
1 primary · 0 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Richard Burr
RRepublican
Ask Maddy
·
AI policy assistant
Ask Maddy about S 4535
Scope: US
Hi! I can help you understand S 4535. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline